華潤雙鶴：CX2101A獲準(zhǔn)開展用于治療新型冠狀病毒肺炎的臨床試驗

array(1) { [463059]=> array(2) { [2]=> array(5) { [0]=> string(6) "藥品" [1]=> string(12) "臨床試驗" [2]=> string(12) "冠狀病毒" [3]=> string(12) "華潤雙鶴" [4]=> string(12) "肺炎疫情" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }